162
Participants
Start Date
September 30, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2029
Trifluridine/tipiracil
35 mg/m², orally
Bevacizumab
5 mg/kg, intravenous route
CHU Amiens, Amiens
Centre Hospitalier Universitaire -Besançon, Besançon
Centre François Baclesse, Caen
Centre Hospitalier Departemental Vendee - Site Des Oudairies, La Roche-sur-Yon
Centre Hospitaler Universitaire de Lille, Lille
Hôpital privé Jean MERMOZ, Lyon
CHU Saint-Antoine, Paris
Institut Saint Catherine, Paris
CHU de BORDEAUX Hôpital HAUT-LEVEQUE, Pessac
Institut de cancérologie Strasbourg Europe, Strasbourg
Servier
INDUSTRY
GERCOR - Multidisciplinary Oncology Cooperative Group
OTHER